Overview
Aortopathy — dilation, aneurysm, or dissection of the aorta — is an increasingly recognized complication in patients with congenital heart disease, connective tissue disorders, and bicuspid aortic valve. Proactive surveillance and timely intervention can prevent catastrophic aortic events and preserve long-term cardiovascular health.
Understanding Aortopathy in CHD
Aortopathy in the CHD population arises from intrinsic aortic wall abnormalities (cystic medial necrosis, elastin fragmentation) compounded by hemodynamic stress from conditions like bicuspid aortic valve, coarctation of the aorta, tetralogy of Fallot, and truncus arteriosus. Genetic syndromes such as Marfan, Loeys-Dietz, and Turner syndrome add further risk. Understanding the underlying mechanism guides surveillance intervals and intervention thresholds.
Imaging & Surveillance
Aortic surveillance relies on serial imaging — echocardiography for the aortic root, CT angiography or MRA for the ascending aorta, arch, and descending segments. Measurements must be indexed to body surface area and tracked longitudinally at consistent anatomic landmarks. Growth rates exceeding 3–5 mm per year, or absolute diameters reaching established thresholds, trigger escalation to surgical consultation.
Medical & Surgical Management
Medical management includes blood pressure optimization (targeting beta-blockers or ARBs), lifestyle modification (avoidance of isometric exercise and contact sports in severe cases), and genetic counseling for heritable aortopathies. Surgical intervention — valve-sparing root replacement, ascending aortic replacement, or endovascular stent grafting — is recommended when aortic dimensions exceed guideline thresholds or rapid growth is documented.
Genetic Counseling & Family Screening
Many aortopathies have a heritable component. First-degree relatives of patients with bicuspid aortic valve, Marfan syndrome, or familial thoracic aortic aneurysm should undergo screening echocardiography. Genetic testing can clarify risk and guide family-wide surveillance strategies, turning a single patient's diagnosis into a family health asset.
Who Is This For?
- Patients with bicuspid aortic valve and aortic dilation
- Adults with CHD and known or suspected aortic enlargement
- Patients with Marfan, Loeys-Dietz, Turner, or other connective tissue syndromes
- Families with a history of aortic aneurysm or dissection seeking screening